Home > Healthcare > Medical Devices > Diagnostic Devices > Hematology Diagnostics Market

Hematology Diagnostics Market Share

Report ID: GMI5640
Published Date: May 2023
Report Format: PDF

Download Free Sample

Hematology Diagnostics Market Share

Some of the major players operating in the hematology diagnostics market are:

Abbott Laboratories
BAG Healthcare Ltd
Beckman Coulter Inc
Bio Rad Laboratories
BioSystems
Boule Diagnostics
Danaher Corporation
Diatron
F. Hoffmann-La Roche Ltd
HemoCue AB
HORIBA
Mindray
Medical International Limited
Nihon Kohden
Ortho Clinical Diagnostics
Siemens Healthcare
Sysmex Corporation

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for hematology diagnostics was USD 3.8 billion in 2022 and will reach over USD 5.9 billion by the end of 2032 due to the surging prevalence of chronic conditions, such as blood and blood disorders worldwide.

Instruments held over 62% of the hematology diagnostics market share in 2022 and will witness expansion through 2032 owing to increasing penetration in blood screening and diagnostics.

U.S. hematology diagnostics share is estimated to reach USD 2.1 billion by 2032 on account of the strong presence of several market participants to focus on the development of innovative products for better patient management.

Abbott Laboratories, BAG Healthcare Ltd., Beckman Coulter, Inc., Bio Rad Laboratories, BioSystems, Boule Diagnostics, Danaher Corporation, Diatron, F. Hoffmann-La Roche Ltd., HemoCue AB, HORIBA, and Mindray are some major hematology diagnostics business players.